1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [d7f1af5d-b938-4f00-a62b-130c7dc1150b] => Array ( [runtime-id] => d7f1af5d-b938-4f00-a62b-130c7dc1150b [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [0a94d6f4-ea5a-4831-a7bd-e1fd8834995e] => Array ( [runtime-id] => 0a94d6f4-ea5a-4831-a7bd-e1fd8834995e [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;604fac0265f7344bf33eb35dca1b451d76bcc2a0 ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [d7f1af5d-b938-4f00-a62b-130c7dc1150b] => Array ( [runtime-id] => d7f1af5d-b938-4f00-a62b-130c7dc1150b [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [0a94d6f4-ea5a-4831-a7bd-e1fd8834995e] => Array ( [runtime-id] => 0a94d6f4-ea5a-4831-a7bd-e1fd8834995e [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;604fac0265f7344bf33eb35dca1b451d76bcc2a0 ) ) )Table 4:IIH-related MR imaging findings before venous sinus stent placement and at 6-month follow-upa
MR Imaging Findings Evaluation Possible (%) (No.) Before Venous Sinus Stent Placement At 6-Month Follow-Up P Values Meckel cave (mm) 100% (26/26) 4.3 (4.0–4.9) 4.1 (3.4–5.1) .096 Empty sella (mm) 100% (13/13) 4.9 (3.5–6.9) 4.9 (3.2–7.0) .753 Tonsillar ectopia (mm) 100% (13/13) −1.1 (−1.9 to –1.9) −0.67 (−1.3 to −0.9) .600 Lateral ventricles (mm) 100% (13/13) 31.5 (29.4–34.6) 32.2 (29.7–34.6) .124 Third ventricle corpus (mm) 100% (13/13) 3.7 (3.2–4.2) 4.5 (3.5–5.2) .075 Optic nerve sheath diameter (mm) 100% (26/26) 6.8 (6.2–7.3) 6.1 (5.9–6.5) .000 Optic nerve protrusion (%) 100% (26/26) Posterior globe involvement (%) 100% (26/26) .001 Normal convexity of the optic globe 38.5% (10) 84.6% (22) Posterior globe flattening 30.8% (8) 15.4% (4) Posterior globe flattening with optic nerve protrusion 30.8% (8) 0.0% (0) Extracranial findings Proximal emissary vein (mm) 84.6% (11/13) 1.6 (0.6–2.3) 1.6 (0.6–2.4) .790 Subcutaneous fat thickness in the scalp (mm) 100% (13/13) 4.1 (3.8–4.3) 4.1 (3.5–4.6) .834 Subcutaneous fat thickness in the neck (mm) 100% (13/13) 8.9 (7.3–11.2) 7.4 (5.9–8.3) .001
a Data are expressed as percentages (No.) or median (interquartile range [25%–75%]).